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Abstract
The DExD/H box RNA helicases retinoic acid-inducible gene-I (RIG-I) and melanoma differentiation associated gene-5 (mda-
5) sense viral RNA in the cytoplasm of infected cells and activate signal transduction pathways that trigger the production of
type I interferons (IFNs). Laboratory of genetics and physiology 2 (LGP2) is thought to influence IFN production by
regulating the activity of RIG-I and mda-5, although its mechanism of action is not known and its function is controversial.
Here we show that expression of LGP2 potentiates IFN induction by polyinosinic-polycytidylic acid [poly(I:C)], commonly
used as a synthetic mimic of viral dsRNA, and that this is particularly significant at limited levels of the inducer. The observed
enhancement is mediated through co-operation with mda-5, which depends upon LGP2 for maximal activation in response
to poly(I:C). This co-operation is dependent upon dsRNA binding by LGP2, and the presence of helicase domain IV, both of
which are required for LGP2 to interact with mda-5. In contrast, although RIG-I can also be activated by poly(I:C), LGP2 does
not have the ability to enhance IFN induction by RIG-I, and instead acts as an inhibitor of RIG-I-dependent poly(I:C)
signaling. Thus the level of LGP2 expression is a critical factor in determining the cellular sensitivity to induction by dsRNA,
and this may be important for rapid activation of the IFN response at early times post-infection when the levels of inducer
are low.
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Introduction
The innate immune system detects invading micro-organisms
by sensing the presence of pathogen-specific macromolecules
termed pathogen-associated molecular patterns (PAMPs) which
display key structural features that identify them as non-self.
Mammalian cells express a number of pattern recognition
receptors (PRRs) which are responsible for detecting a variety of
different PAMPs of bacterial, viral and fungal origin [1]. Their
activation stimulates signal transduction pathways that result in
innate immune responses including the production of type I
interferons (IFN) which play a vital role in controlling infection.
Cytoplasmic recognition of RNA viruses is mediated by the
retinoic acid-inducible gene (RIG)-I-like receptors, RIG-I, and
melanoma differentiation associated gene-5 (mda-5). These PRRs
sense distinct, but overlapping RNA structures; RIG-I is activated
by short dsRNAs containing a 59 triphosphate [2–4], and although
the precise requirements are less clear, mda-5 appears to be
activated by longer regions of dsRNA and higher-order RNA
structures [5,6].
RIG-I and mda-5 are characterized by the presence of two N-
terminal caspase activation and recruitment domains (CARDs), an
RNA helicase domain, and a C-terminal regulatory domain.
Recognition of viral RNA occurs through the C-terminal and
helicase domains and promotes a conformational change which
reveals the CARD domains for downstream signaling [7].
Activation by extended regions of dsRNA is accompanied by the
appearance of long filaments formed by co-operative multi-
merisation of mda-5 or RIG-I along the length of the dsRNA
molecule [8–10]. In the activated state the CARD domains are
exposed and are free to interact with the downstream adapter
protein IFN-b promoter stimulator (IPS)-1 (also known as MAVS,
Cardif and VISA) which is located on the outer mitochondrial
membrane. IPS-1 acts as a scaffold for the assembly of a large
multiprotein complex which activates the transcription factors
interferon regulatory factor (IRF)-3 and nuclear factor-kB (NF-kB)
which are required for transcriptional activation of the IFN-b
promoter [11,12].
Database searches for proteins related to RIG-I identified a
factor referred to as laboratory of genetics and physiology 2
(LGP2) [13,14]. LGP2 shares considerable homology with RIG-I
and mda-5 within the RNA helicase and C-terminal domains, but
lacks the N-terminal CARD domains that are required for
signaling. Consistent with this LGP2 does not have an intrinsic
ability to activate the IFN-b promoter in transient overexpression
experiments [13].
Interpretation of the relative contributions of RIG-I and mda-5
to IFN induction by specific viruses is complicated by issues such
as the presence of virally-encoded inhibitors of PRRs [15], the
presence of defective interfering (DI) particles in many virus stocks
[16–19], and the use of a wide range of cell lines and primary cell
types in different studies. Nevertheless, a consensus view is that
negative-stranded RNA viruses signal through RIG-I and positive-
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stranded viruses signal through mda-5, although there are
examples of viruses that signal through both [20,21]. The role of
LGP2 in viral infections is less clear. Early experiments showed
that overexpression of LGP2 inhibited IFN induction in response
to Sendai virus (SeV), Newcastle disease virus (NDV) or
polyinosinic-polycytidylic acid [poly(I:C)], a synthetic dsRNA
[13,14,22] and conversely, that knockdown of LGP2 enhanced
activation of an IFN-responsive promoter by NDV. Taken
together with the fact that LGP2 is an avid dsRNA binding
protein it was proposed that LGP2 inhibits IFN induction by
sequestering PAMPs from RIG-I and mda-5 [13,14] However,
studies on LGP2% mice revealed a complex phenotype, which
suggested that LGP2 could play positive as well as negative roles in
IFN induction. LGP2% mouse embryo fibroblasts (MEFs)
produced elevated levels of IFN-b in response to vesicular
stomatitis virus (VSV), and the LGP2% mice were more resistant
to lethal VSV infection than control mice [23]. In contrast, when
these mice were challenged with encephalomyocarditis virus
(EMCV), which activates mda-5 rather than RIG-I, they found
reduced levels of serum IFN and the mice were less resistant to
infection. Thus LGP2 appeared to act as an inhibitor of RIG-I-
dependent IFN induction and an activator of mda-5. This study
also revealed that the importance of LGP2 may vary between
different cell types, since macrophages and bone marrow-derived
dendritic cells (BMDCs), but not MEFs, from LGP2% mice
showed much lower levels of IFN-b production in response to
EMCV than the controls. In more recent work [24], BMDCs from
LGP2% mice were found to produce less IFN-b, not just in
response to EMCV, but also VSV, SeV, Japanese encephalitis
virus (JEV) and Reovirus, which are thought to be activators of
RIG-I [20,25], thus raising the possibility that in some cell types
LGP2 may act as a positive regulator of RIG-I as well as mda-5.
Interestingly, not all viruses required LGP2 to induce IFN, since
IFN induction by influenza A virus was equivalent in the wt and
LGP2% cells [24].
To elucidate the role of LGP2 in the cellular response to PAMPs
we have studied the ability of LGP2 to influence IFN-b induction
by poly(I:C), a molecule generated by the annealing of synthetic
single-stranded polyinosinic acid and polycytidylic acid; the
annealed material lacks 59 triphosphate residues and comprises
long duplexes of dsRNA joined together by unpaired stretches of
polyinosinic acid or polycytidylic acid. These studies are not
complicated by undefined viral transcription or replicative
structures, the presence of unknown types of DI molecules, or
the expression of virally-encoded inhibitors of IFN-b induction.
Although previous publications have shown that LGP2 inhibits
IFN induction by poly(I:C) when the levels of LGP2 and poly(I:C)
are both high [22], we now show that LGP2 is actually a potent
stimulator of poly(I:C) signaling when the levels of transfected
poly(I:C) are limited, and thus the level of LGP2 is critical in
determining cellular sensitivity to induction. We also demonstrate
that this function of LGP2 is dependent upon its ability to activate
mda-5, and is sensitive to inhibition by the PIV5 V protein. In
contrast, although RIG-I can also be activated by poly(I:C), LGP2
does not have the ability to enhance IFN induction by RIG-I, and
instead acts as an inhibitor of RIG-I-dependent poly(I:C) signaling
when expressed at high levels. Thus, the level of LGP2 expression
in a cell may be a crucial factor in shaping the overall IFN
response to dsRNA.
Materials and Methods
Plasmids
The IFN-b promoter reporter plasmid pIFD(2116)lucter [26],
the constitutive b-galactosidase reporter plasmid pJatLacZ [27],
the expression vector pEFplink2 [28], pEF.mda-5, pEF.RIG-I
[29], pEF.Flag.LGP2, pEF.V5.LGP2, pEF.Flag.LGP2(K634E),
pEF.Flag.LGP2DIV [30], pEF.Flag.RIG-I, pEF.Flag.mda-5Heli-
case (MH), pEF.mda-5CARD [31] and pEF.PIV5-V [32] have
been previously described. pCMVSPORT6.IPS-1 was obtained
from the I.M.A.G.E consortium (clone identification no. 5751684)
[33]. pEF.Flag.LGP2DC which encodes amino acids 1–592 of
LGP2, and pEF.Flag.LGP2DN which encodes amino acids 145–
678 of LGP2 were created using standard methods. To make
pEF.Flag.LGP2(K30A) a DNA fragment consisting of the first
183bp of the LGP2 cDNA sequence including a mutation to
generate the K30A amino acid change was synthesised by MWG.
This was used to replace the corresponding sequence in
pEF.Flag.LGP2. LGP2 with helicase motif IV replaced with the
equivalent sequence from RIG-I (pEF.Flag.LGP2(IV)R) was made
by replacing amino acids 369–380 of LGP2 with amino acids 630–
640 of RIG-I using a synthetic DNA fragment (MWG). A
pLKO.1-puro plasmid expressing an shRNA against human
LGP2 was purchased from Sigma-Aldrich (TRCN0000051267).
For yeast two- and three-hybrid assays, cDNAs were cloned into
pGBKT7 or pGADT7 (Clontech) for expression of proteins as
Figure 1. LGP2 enhances IFN induction in response to poly(I:C). (A–C) HEK293 cells were transfected with a reporter plasmid containing the
luciferase gene under the control of the IFN-b promoter, a plasmid constitutively expressing b-galactosidase as a transfection control, and (A) 0.4 ng
plasmids expressing mda-5 or RIG-I, (B) 100 ng plasmid expressing LGP2, or (C) 0–160 ng plasmid expressing LGP2. Total amounts of DNA were kept
constant by supplementing with the empty vector pEFpl2. 24 hours after transfection cells were further transfected with the indicated amounts of
poly(I:C) for 16 hours. Cell lysates were analysed for luciferase and b-galactosidase activity, and relative expression levels calculated. The effect of
LGP2 on induction by poly(I:C) is statistically significant (p,0.01).
doi:10.1371/journal.pone.0064202.g001
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GAL4 DNA-binding domain (DBD) or GAL4 activation domain
(AD) fusions respectively. pGBKT7.mda-5H and pGADT7.mda-
5H, encoding the helicase domain (amino acids 287–1025) of
mda-5, pGBKT7.LGP2, pGBKT7.LGP2(IV)R, pHON7,
pHON7.PKR(1–207), pHON7.PKR.M2(1–207) and pHON7.-
PIV5-V have been described elsewhere [30,31]. The cDNA
encoding LGP2 was cloned between the NcoI and EcoRI sites of
pGADT7 to generate pGADT7.LGP2. pGADT7.LGP2(K634E)
was created by PCR site-directed mutagenesis using standard
methods. pGBKT7.LGP2(1–464) was created by cloning a PciI-
NcoI fragment of the LGP2 cDNA into the NcoI site of pGBKT7,
and pGBKT7.LGP2(145–678) was created by cloning a BspHI-
EcoRI fragment of the LGP2 cDNA between the NcoI and EcoRI
sites of pGBKT7.
Cells, transfections and siRNAs
HEK-293 cells (ATCC CRL-1573) were maintained in
Dulbecco’s modification of Eagle’s medium (DMEM) + 10% fetal
bovine serum (FBS) and penicillin/streptomycin. Transfections
were carried out using linear polyethyleneimine (PEI),
MW,25,000 (Polysciences Inc, Warrington PA, USA) or
Lipofectamine (InVitrogen) under standard conditions. Luciferase
and b-galactosidase assays were carried out 48h after transfection,
and luciferase activity was corrected to b-galactosidase activity.
Experiments were repeated at least three times, and average values
are presented with error bars indicating the range of values
obtained from the replicates. The siRNA against mda-5 is
Hs_IFIH1_2 (Qiagen cat no S100445851), the RIG-I siRNA is
Hs_DDX58_1 (Qiagen cat no S100361809), and the control
siRNA used was against an unrelated protein LRRC37A (Qiagen
cat no S100622874). The synthetic double-stranded RNA,
polyinosinic-polycytidylic acid [poly(I:C)] was purchased from
GE Healthcare Lifesciences (Cat. 27-4732-01), and dissolved in
PBS to make a working solution of 1mg/ml which was stored at
220uC. The average length of RNA duplex in the single batch of
poly(I:C) used in these experiments was determined by nuclease
resistance to range from 200bp to 1000bp with a mean of 500bp.
Duplexes are connected by single-stranded regions of RNA of
indeterminate length, generating a set of molecules that average
over 10kb when compared with dsDNA markers. IFN treatments
and inductions with poly(I:C) were carried out as described
previously [31].
Co-immunoprecipitations and immunoblotting
To make cell extracts, 6cm dishes of cells were washed with PBS
then lysed in 500 ml lysis buffer (50 mM Tris-HCl pH 7.5,
150 mM NaCl, 1 mM EDTA, 1% NP-40). 100 ml extract was
used for co-immunoprecipitation assays using a mouse monoclonal
antibody against the Flag tag (Sigma F3165). Complexes were
collected on protein A-Sepharose beads (GE Healthcare), washed
three times with 1 ml lysis buffer, and eluted in SDS-PAGE
loading buffer. Proteins were separated by SDS-PAGE, and
immunoblotting was performed using antibodies to the Flag or V5
tags, a-tubulin (Sigma cat. T9026), mda-5 (Alexis Biochemicals
AT113) or LGP2 (Abcam, cat. ab67270). Bound primary
antibodies were detected using either HRP-conjugated Sheep
Anti-mouse Ig or donkey anti-rabbit whole antibody (GE
Healthcare).
Figure 2. LGP2 stimulation of poly(I:C) signaling is dependent upon endogenous mda-5. HEK293 cells were transfected with the IFN-b
reporter plasmid, the b-galactosidase expression plasmid, either the empty vector pEFpl2 or pEF.LGP2, and either a control siRNA (A), an siRNA
directed against RIG-I (B), or an siRNA directed against mda-5 (C). 24 hours after transfection cells were further transfected with the indicated amounts
of poly(I:C) for 16 hours. Cell lysates were analysed for luciferase and b-galactosidase activity, and relative expression levels calculated. (D) The
effectiveness of siRNAs against RIG-I and mda-5 was tested by immunoblotting. HEK293 cells were transfected with a vector expressing Flag-tagged
RIG-I and either a control siRNA or the RIG-I siRNA (upper panel). Cells transfected with either the control siRNA or the mda-5 siRNA were exposed to
IFN for 16hrs to induce mda-5 expression (lower panel). Cell extracts were subjected to immunoblotting with either anti-Flag (for RIG-I detection),
anti-mda-5 or anti-tubulin as a loading control.
doi:10.1371/journal.pone.0064202.g002
Figure 3. LGP2 co-operates with mda-5 but not RIG-I to
promote poly(I:C) signaling. HEK293 cells were transfected with
the IFN-b reporter plasmid, the b-galactosidase expression plasmid, and
combinations of plasmids expressing mda-5 (0.4 ng), RIG-I (0.4 ng) or
LGP2 (2 ng). 24 hours after transfection cells were further transfected
with increasing amounts of poly(I:C) for 16 hours. Cell lysates were
analysed for luciferase and b-galactosidase activity, and relative
expression levels calculated.
doi:10.1371/journal.pone.0064202.g003
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Yeast two- and three-hybrid assays
Combinations of GAL4 DBD and GAL4 AD fusion plasmids
were introduced into Saccharomyces cerevisiae strain PJ69-4a using
standard methods. Double transformants were selected on
synthetic dropout (SD) medium lacking leucine and tryptophan
(SD-L-W), and subsequently streaked onto SD-L-W medium also
lacking histidine (SD-L-W-H) and containing 2 mM 3-aminotria-
zole (3-AT). Growth was monitored for up to 6 days at 30uC.
When the pHON7-derived third plasmid was used, triple
transformants were selected on SD medium lacking leucine,
tryptophan and uracil (SD-L-W-U), and individual colonies were
subsequently streaked onto SD-L-W-U medium also lacking
histidine and containing 2 mM 3-AT (SD-L-W-U-H).
Results
LGP2 enhances IFN induction in response to poly(I:C)
Overexpression of either mda-5 or RIG-I significantly increases
IFN induction in response to the synthetic dsRNA, poly(I:C), in
HEK293 cells (Fig 1A). Under these conditions the sensitivity to
activation of mda-5 or RIG-I by poly(I:C) is indistinguishable. To
examine the properties of LGP2, we looked at the effect of LGP2
overexpression on poly(I:C) signaling and found that it could also
enhance IFN induction (Fig 1B), but to a lower level than mda-5
and RIG-I (note the different scales in Figs 1A and 1B).
Interestingly, this effect was most pronounced at lower levels of
transfected poly(I:C). Next, we analysed the effect of increasing
amounts of LGP2 on activation of the IFN-b promoter by a fixed
amount of poly(I:C). For this experiment we chose to use a low
dose of poly(I:C) (2 ng) that barely activated the IFN-b promoter
over the uninduced control in the absence of exogenous LGP2 in
order to better reveal the effect of LGP2 expression. We found that
transfection of cells with a plasmid expressing LGP2 resulted in a
considerable dose-dependent increase in the level of IFN induction
(Fig 1C). These experiments show that LGP2 is a potent stimulator
of poly(I:C) signaling, particularly when the amounts of the
inducer are limited.
LGP2 stimulation of poly(I:C) signaling is dependent
upon endogenous mda-5
Since LGP2 lacks a CARD domain, we hypothesized that the
ability of LGP2 to promote poly(I:C) signaling would be
dependent upon endogenous mda-5 or RIG-I. To test this we
performed the experiment in the presence of either a control
siRNA (Fig 2A), a RIG-I siRNA (Fig 2B) or an mda-5 siRNA
(Fig 2C). The effectiveness of these siRNAs in knocking down
expression of RIG-I and mda-5 in HEK293 cells is shown in
Fig 2D. These experiments show that LGP2 is capable of
promoting poly(I:C) signaling in the presence of the control or
the RIG-I siRNAs, but no induction is observed in the presence of
the mda-5 siRNA. Therefore, mda-5 but not RIG-I, is required for
the increased IFN induction by poly(I:C) observed upon overex-
pression of LGP2.
We next looked to see if LGP2 expression affects the ability of
mda-5 and RIG-I to be activated by poly(I:C). Strikingly, when
LGP2 was co-expressed with mda-5, the maximum level of IFN
promoter activity was reached at a much lower concentration of
poly(I:C) than in the presence of either mda-5 or LGP2 alone
(Fig 3A), indicating that LGP2 is able to synergize with mda-5 to
render cells considerably more sensitive to induction by poly(I:C).
In contrast, LGP2 did not enhance the ability of RIG-I to induce
IFN in response to poly(I:C) (Fig 3B). In fact, LGP2 is known to act
as an inhibitor of RIG-I signaling, but it has been shown that this
requires considerably more LGP2 than activation of mda-5
[30,34]. Accordingly, we found that higher levels of LGP2
expression inhibited RIG-I-dependent poly(I:C) signaling (Fig S1).
LGP2 is required for optimal mda-5-dependent IFN
induction
Although it is clear that LGP2 requires mda-5 to promote
poly(I:C) signaling, presumably due to the absence of a CARD
domain in LGP2, it is not clear whether the efficient activation of
mda-5 seen in response to poly(I:C) requires LGP2. We therefore
Figure 4. LGP2 knockdown cells induce less IFN in response to
poly(I:C) than wild-type cells. (A) Extracts from parental HEK293
cells and stable cell lines expressing an shRNA against LGP2 were
subjected to western blotting with antibodies against LGP2 or a-tubulin
as a loading control. (B) Parental HEK293 cells and LGP2 knockdown
cells were transfected with the IFN-b reporter plasmid and the b-
galactosidase expression plasmid. 24 hours after transfection cells were
further transfected with poly(I:C) for 16 hours. (C) Parental HEK293 cells
and LGP2 knockdown cells were transfected with the IFN-b reporter
plasmid, the b-galactosidase expression plasmid, and either the empty
vector pEFpl2 or pEF.LGP2. 24 hours after transfection cells were further
transfected with poly(I:C) for 16 hours where indicated. (D) Parental
HEK293 cells and LGP2 knockdown cells were transfected with the IFN-b
reporter plasmid, the b-galactosidase expression plasmid, and plasmids
expressing mda-5, LGP2 or IPS-1. (E) HEK293 cells were transfected with
the IFN-b reporter plasmid, the b-galactosidase expression plasmid and
plasmids expressing IPS-1, the CARD domains of mda-5 or LGP2 as
indicated. Cell lysates were analysed for luciferase and b-galactosidase
activity, and relative expression levels calculated.
doi:10.1371/journal.pone.0064202.g004
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generated stable cell lines expressing an shRNA against LGP2 in
order to study the requirement for LGP2 in mda-5-dependent IFN
induction. Knockdown of LGP2 in six independent cell lines was
verified by western blotting (Fig 4A). Firstly, we examined the
ability of these cell lines to induce IFN in response to poly(I:C),
and found that in comparison to the parental HEK293 cells the
LGP2 knockdown cells responded very poorly (Fig 4B). Two of
these cell lines (sh2 and sh3) which showed the least responsiveness
to poly(I:C) were chosen for further analysis. To confirm that the
defect in IFN induction was in fact due to a lack of LGP2, we
overexpressed LGP2 and confirmed that the response to poly(I:C)
could be fully restored in both cell lines (Fig 4C). We then looked
at IFN induction in these lines in response to mda-5 overexpres-
sion, and showed that the level of induction was at least 50% lower
in the shRNA-expressing cells than in the control HEK293 cells
(Fig 4D). Again this could be restored by overexpression of LGP2.
Normal levels of IFN induction were observed in response to
overexpression of IPS-1, indicating that these cells do not have a
defect in the signaling pathway downstream of mda-5 which could
explain the lack of IFN induction. These data show that LGP2 is
required for optimal IFN induction through mda-5. Furthermore,
overexpression of LGP2 had no effect on IFN induction by IPS-1
or by the isolated CARD domains of mda-5 (Fig 4E), indicating
that mda-5 itself, and more specifically the helicase domain of
mda-5, is the point of action of LGP2.
Analysis of the domains of LGP2 required for stimulation
of poly(I:C) signaling
To analyse the domains of LGP2 required to stimulate poly(I:C)
signaling, we generated plasmids expressing altered forms of the
protein (Fig 5A). Removal of the C-terminal 86 amino acids
(LGP2DC) or the N-terminal 144 amino acids (LGP2DN)
inactivated the ability of LGP2 to promote IFN induction in
response to poly(I:C), or to stimulate mda-5 (Fig 5B). These altered
forms of LGP2 were also unable to rescue the ability of cell lines
expressing an LGP2 shRNA to respond to poly(I:C) (Fig 5E). Both
truncations retained the ability to inhibit RIG-I exhibited by intact
LGP2(Fig 5B).
We also generated two single amino acid substitution forms of
LGP2. One of these, LGP2(K30A), lacks ATPase activity but still
binds dsRNA [35]; the other, LGP2(K634E), is unable to bind
dsRNA [34,36]. LGP2(K30A) stimulated IFN induction in
response to both poly(I:C) and mda-5 overexpression (Fig 5C),
and was also able to rescue induction by poly(I:C) in the LGP2
knockdown cells (Fig 5E), indicating that the ATPase activity of
LGP2 is dispensable for stimulation of signaling through mda-5 by
poly(I:C). By contrast, LGP2(K634E) showed impaired ability to
stimulate poly(I:C) or mda-5 signaling (Fig 5C), and only partially
rescued the phenotype of the cell lines expressing the LGP2
shRNA (Fig 5E), indicating that the dsRNA binding activity of
LGP2 is important for the ability of LGP2 to promote signaling
Figure 5. Analysis of the regions of LGP2 required for stimulation of poly(I:C) signaling. (A) Schematic diagram of LGP2 mutants. (B–E)
HEK293 cells or LGP2 knockdown cells were transfected with the IFN-b reporter plasmid, the b-galactosidase expression plasmid, and plasmids
expressing mda-5, RIG-I, LGP2, or various mutants of LGP2. 24 hours after transfection cells were further transfected with poly(I:C) for 16 hours where
indicated. Cell lysates were analysed for luciferase and b-galactosidase activity, and relative expression levels calculated. The average of three
independent experiments is shown. (F) HEK293 cells were transfected with plasmids expressing Flag-tagged mutants of LGP2. Lysates of transfected
cells were subjected to western blotting using an anti-Flag antibody to confirm expression.
doi:10.1371/journal.pone.0064202.g005
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through mda-5. Consistent with previous reports, both
LGP2(K30A) and LGP2(K634E) were able to inhibit RIG-I
[35,36].
The helicase domains of mda-5, RIG-I and LGP2 are
characterized by the presence of six motifs designated I–VI. We
have previously demonstrated that a twelve amino acid region
encompassing motif IV, which is completely conserved between
mda-5 and LGP2 but which contains 6 amino acid differences in
RIG-I, is critical for binding of the paramyxovirus V proteins to
mda-5 and LGP2 [30]. To determine whether this region plays a
role in the co-operation between LGP2 and mda-5, we generated
a plasmid expressing LGP2 with a deletion of amino acids 369–
380 which encompasses motif IV (LGP2DIV). This completely
abolished the ability of LGP2 to stimulate IFN induction in
response to both poly(I:C) and mda-5 (Fig 5D). We also introduced
a more subtle change by substituting amino acids 369–380 with
the equivalent region of RIG-I. This protein (LGP2[IV]R) also
failed to stimulate mda-5, indicating that amino acids 369–380 of
LGP2 are crucial to the co-operation between mda-5 and LGP2.
In addition, neither LGP2DIV or LGP2(IV)R were able to rescue
the ability of the LGP2 knockdown cells to respond to poly(I:C)
(Fig 5E). Interestingly, like the other mutants, deletion of motif IV
had no effect on the ability of LGP2 to inhibit IFN induction
through RIG-I, demonstrating that the mechanisms that are
responsible for mda-5 activation and RIG-I inhibition are distinct
and separable.
LGP2 interacts with mda-5 in a dsRNA-dependent
manner
To determine whether the co-operative effect between LGP2
and mda-5 that we observed in the reporter gene assays in
response to poly(I:C) is accompanied by a physical association
between these two proteins, a co-immunoprecipitation assay was
carried out. HEK-293 cells expressing a FLAG-tagged helicase
domain of mda-5 and V5-tagged LGP2 were transfected with
poly(I:C). No interaction between mda-5 and LGP2 was observed
Figure 6. LGP2 interacts with mda-5 in a dsRNA-dependent
manner. (A) HEK293 cells were transfected with a plasmid expressing
the helicase domain of mda-5 with a Flag tag (Flag.MH) and a plasmid
expressing LGP2 with a V5 tag (V5.LGP2). 24 hours after transfection,
cells were transfected with poly(I:C) for the indicated times. Cell extracts
were subjected to immunoprecipitation with the anti-flag antibody, and
proteins present in the precipitate were analysed by western blotting
with anti-V5 and anti-flag antibodies. (B) Yeast cells were transformed
with a plasmid expressing the helicase domain of mda-5 as a GAL4DBD
fusion, and a plasmid expressing LGP2 or the indicated mutants of LGP2
as a GALAD fusion. Positive transformants were selected on SD-L-W,
and growth on this media indicates that the yeast have been
transformed by both plasmids. They were then streaked onto SD-L-W-
H + 2 mM 3-AT and growth on this media demonstrates an interaction
between the GAL4DBD fusion protein and the GAL4AD fusion protein.
(C) Yeast cells were transformed with a plasmid expressing the helicase
domain of mda-5 as a GAL4DBD fusion, a plasmid expressing LGP2 as a
GAL4AD fusion and either the empty vector pHON7 (2), pHON7
expressing the dsRNA binding domains of PKR (PKR(1–207)) or pHON7
expressing a mutant form of PKR that is unable to bind dsRNA (M2(1–
207)). Positive transformants were selected on SD-L-W-U, and growth
on this media indicates that the yeast have been transformed by all
three plasmids. They were then streaked onto SD-L-W-U-H + 2 mM 3-AT
and growth on this media demonstrates an interaction between the
GAL4DBD fusion protein and the GAL4AD fusion protein.
doi:10.1371/journal.pone.0064202.g006
Figure 7. PIV5-V blocks the interaction between mda-5 and
LGP2 to inhibit IFN induction. (A) Yeast cells were transformed with
a plasmid expressing the helicase domain of mda-5 as a GAL4DBD
fusion, a plasmid expressing LGP2 as a GAL4AD fusion and either the
empty vector pHON7 (2) or pHON7 expressing the V protein from PIV5
(PIV5-V). Positive transformants were selected on SD-L-W-U and
subsequently streaked onto SD-L-W-U-H + 5 mM 3-AT to assay for an
interaction between the GAL4DBD fusion protein and the GAL4AD
fusion protein. (B) HEK293 cells were transfected with the IFN-b reporter
plasmid, the b-galactosidase expression plasmid and either the empty
vector pEFpl2 (2), pEF.LGP2 or pEF.PIV5-V as indicated. 24 hours after
transfection cells were further transfected with 2 ng poly(I:C) for 16
hours. Cell lysates were analysed for luciferase and b-galactosidase
activity, and relative expression levels calculated.
doi:10.1371/journal.pone.0064202.g007
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in untreated cells, but upon stimulation with poly(I:C) LGP2 was
associated with mda-5 within 2 hours (Fig 6A). This interaction
was confirmed in yeast (Fig 6B). We have previously shown that
mda-5 can interact with itself in the yeast two-hybrid assay, and
that this is dependent on dsRNA present within the yeast strain,
because it can be blocked by co-expression of the dsRNA binding
domain of PKR (PKR[1–207]; [31]). We therefore repeated this
experiment using mda-5 and LGP2, and as we found for mda-5
oligomerisation, the interaction between mda-5 and LGP2 could
be blocked by PKR(1–207) but not by a mutant form of PKR
which is defective in dsRNA binding activity (M2(1–207)) (Fig 6C).
LGP2(K634E) which does not bind dsRNA, did not interact with
mda-5, thus confirming the dsRNA-dependence of this interac-
tion. Also, replacement of domain IV of LGP2 with domain IV of
RIG-I (LGP2(IV)R) abolished the ability of LGP2 to bind mda-5
(Fig 6B).
PIV5-V blocks the interaction between mda-5 and LGP2
to inhibit IFN induction
The V protein encoded by members of the Paramyxovirinae
subfamily of paramyxoviruses can bind to both mda-5 and LGP2
to inhibit IFN induction [30,37]. V blocks activation of mda-5 by
preventing it from oligomerising in the presence of dsRNA, and
we have shown that the ability of the mda-5 helicase domain to
self-associate in yeast can be blocked by co-expression of the V
protein from the paramyxovirus PIV5 (PIV5-V). We therefore
used this yeast based assay to determine whether the interaction
between mda-5 and LGP2 could also be blocked by PIV5-V, and
indeed we found that this was the case (Fig 7A). We also found that
PIV5-V was able to block LGP2-dependent IFN induction in the
presence of poly(I:C) (Fig 7B).
Discussion
The data presented here demonstrate that LGP2 acts as a
potent stimulator of IFN induction by poly(I:C), and that this effect
is particularly significant when very low concentrations of poly(I:C)
are used. This indicates that LGP2 is a limiting factor for IFN
induction by poly(I:C) in HEK293 cells, a cell line commonly used
to study IFN induction. We have shown that the ability of LGP2 to
stimulate IFN production is dependent upon endogenous mda-5,
and that mda-5 and LGP2 can co-operate to increase the
sensitivity of cells to induction by poly(I:C). This, together with
the demonstration that mda-5 and LGP2 form a physical
association in response to poly(I:C), leads us to propose a model
in which a heterodimer or heterooligomer of mda-5 and LGP2
represents a PRR for poly(I:C). This idea is supported by
experiments on MEFs from mda-5/LGP2 double knockout mice
which fail to make IFN-b in response to EMCV infection.
Overexpression of both mda-5 and LGP2 rescued the ability of
these cells to respond to EMCV, whereas either one alone was not
sufficient [24]. A notable feature of mda-5 activation is the
formation of long filaments in which mda-5 dimers co-operatively
bind along the length of the dsRNA molecule [9,10,38]. In light of
the ability of LGP2 to co-operate with mda-5 to induce IFN, a key
question that needs to be addressed is whether LGP2 has a role in
the formation or the stability of these filaments and whether it also
becomes incorporated into the structure.
Although poly(I:C) can activate both mda-5 and RIG-I, we saw
no evidence that LGP2 can stimulate poly(I:C) signaling through
RIG-I. Our data clearly demonstrate that the co-operative effect
observed between LGP2 and mda-5 in the presence of poly(I:C)
(Fig 3A), does not occur between LGP2 and RIG-I (Fig 3B).
Indeed LGP2 instead acts as an inhibitor of RIG-I, but only when
the levels of LGP2 are high. Therefore, if LGP2 does play a
negative role in RIG-I signaling in vivo, it may only occur in cells in
which the levels of LGP2 are in considerable excess over RIG-I.
An exception to this occurs in cells infected with paramyxoviruses,
where the expressed V protein is able to repress RIG-I in a
manner that depends upon binding to LGP2 [30].
LGP2 with a single amino acid substitution which disrupts ATP
binding and hydrolysis, LGP2(K30A), retained the ability to
stimulate poly(I:C) signaling and mda-5 activity (Fig 5C). How-
ever, whereas reconstitution of LGP2% cells with wild-type LGP2
restored their ability to induce IFN in response to EMCV,
LGP2(K30A) was ineffective, suggesting that the ATPase activity
of LGP2 is required for mda-5-dependent IFN induction by
EMCV [24]. Recent work by Bruns et al has shown that LGP2 has
a relatively high basal level of ATP hydrolysis, and that this
facilitates the recognition of a greater diversity of dsRNA
substrates, including molecules that bind relatively weakly to
LGP2 in the absence of ATP [39]. Since LGP2 binds poly(I:C)
very effectively in a manner that does not depend on ATP, we
suggest that there would be no requirement for the ATP hydrolysis
activity of LGP2 to stimulate mda-5 or poly(I:C) signaling.
Interestingly, LGP2(K30A) was a stronger activator of IFN
induction in response to poly(I:C) than wild-type LGP2 (Fig 5C).
The reason for this is unclear, but mda-5-catalysed ATP hydrolysis
has been linked to the dissociation of mda-5 filaments from
dsRNA [9,38]. Although LGP2 has yet to be linked to the
formation of mda-5 filaments, if it is incorporated into the
structure, the ATPase activity of LGP2 could also be involved in
disassembly. The presence of LGP2(K30A) could therefore result
in increased stability of the filaments and consequently lead to
increased IFN production.
The dsRNA binding defective form of LGP2(K634E) did not
stimulate poly(I:C) signaling as efficiently as wtLGP2 (Fig 5C),
suggesting that dsRNA binding is involved in stimulation of
poly(I:C) signaling through mda-5. Since the relative affinity of
mda-5 for poly(I:C) is low compared to RIG-I and LGP2 (14 and
our unpublished data), an attractive model would be one in which
LGP2 binds poly(I:C) and helps to recruit mda-5.
We also reveal a critical role for amino acids 369–380 of LGP2
in stimulation of mda-5, since their deletion resulted in a protein
which was completely unable to activate IFN induction by
poly(I:C) or mda-5. Interestingly, this twelve amino acid region
encompassing domain IV is completely conserved between mda-5
and LGP2, but is only 50% identical in RIG-I. Replacement of
domain IV of LGP2 with the equivalent sequence from RIG-I
resulted in a defective protein, demonstrating that the particular
residues common to mda-5 and LGP2 are critical to the ability of
LGP2 to stimulate signaling through mda-5. It is interesting to
note that this same region is also required for the binding of
paramyxovirus V proteins to mda-5 and LGP2 [30,31], and
indeed, we observed that PIV5-V was able to disrupt the
interaction between mda-5 and LGP2. It is interesting to speculate
that these viruses may have evolved the ability to target this
particular region in order to prevent the synergistic effect of their
association.
With its important role in regulating activation of mda-5 and
thereby determining the sensitivity of cells to induction by mda-5
ligands, and its additional role in providing a brake on RIG-I-
dependent IFN induction, the level of LGP2 expression in a cell
may actually be a crucial factor in shaping the overall IFN
response. Although there is still much work to be done to fully
define the role of LGP2 in regulating IFN induction in response to
different viral infections, it is clear that this important regulator has
a much more complex role than at first envisaged.
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Supporting Information
Figure S1 At high concentrations, LGP2 inhibits RIG-I-
dependent poly(I:C) signaling. HEK293 cells were transfect-
ed with the IFN-b reporter plasmid, the b-galactosidase expression
plasmid and plasmids expressing RIG-I (0.4 ng) or LGP2 (100 ng).
24 hours after transfection cells were further transfected with
increasing amounts of poly(I:C) for 16 hours. Cell lysates were
analysed for luciferase and b-galactosidase activity, and relative
expression levels calculated.
(TIF)
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